A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches
NCT00134927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2017-01-10
Summary
Since 1996, the nicotine patch has been re-classified from prescription to over-the-counter (OTC) status in the United States. Little is known about how the public uses the OTC nicotine patch due to lack of monitoring. The purpose of this observational study is to describe the characteristics of consumers who purchase OTC nicotine patches from community pharmacies and to determine the factors associated with the appropriate use of nicotine patches.
Conditions
- Nicotine Dependence
- Tobacco Use Disorder
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Chih-Wen Shi, M.D., M.S. · University of California, San Diego
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2006-05-31
- Completion
- 2006-11-30
Countries
- United States
Study Locations
More Related Trials
-
Abuse Liability and Appeal of Oral Nicotine Products
NCT06506162 ·Status: RECRUITING ·Phase: NA
-
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers
NCT00711100 ·Status: COMPLETED ·Phase: NA
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
NCT07099638 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1
NCT00218140 ·Status: COMPLETED ·Phase: PHASE2
-
Providing Free Nicotine Patches to Quitline Smokers
NCT01736085 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Nicotine Receptor Density & Response to Nicotine Patch
NCT01526005 ·Status: COMPLETED
-
Electronic Cigarettes in Daily Dependent Smokers
NCT02108626 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Metabolites in Nicotine Dependence (4) - 13
NCT00000296 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Replacement Therapy in Nicotine-dependent Arrestees
NCT02905734 ·Status: COMPLETED ·Phase: PHASE4
-
CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches
NCT05294497 ·Status: COMPLETED ·Phase: NA
-
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
NCT05280769 ·Status: COMPLETED ·Phase: NA
-
Effects of Nicotine in Tobacco Smokers
NCT03651869 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving
NCT01466361 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Metabolites in Nicotine Dependence (3) - 6
NCT00000289 ·Status: COMPLETED ·Phase: PHASE2
-
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
NCT00939029 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
NCT01075659 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment for Nicotine Addiction in Women
NCT02448654 ·Status: COMPLETED ·Phase: NA
-
Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
NCT00392379 ·Status: COMPLETED ·Phase: PHASE3
-
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
NCT02870218 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced Nicotine Cigarette Purchasing Decisions
NCT04999644 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
NCT00313105 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Different E-cigarette Cooling Flavors on Adults' Sensory Experience TCORS 3.0
NCT05932693 ·Status: COMPLETED ·Phase: NA